| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Dipartimenti di Biologia e Patologia Cellulare e Molecolare (R.S., S.Lib., P.L.P., D.S.-C., A.F., G.P.), Scienze Biomorfologiche e Funzionali-Istituto di Anatomia Patologica (G.T., L.P.), and Chimica Biologica (P.L.), Università Federico II, 80131 Naples, Italy; Cancer Research U.K. Centre for Cancer Therapeutics (V.B., S.Lin.), Institute of Cancer Research 15, Belmont, Sutton, Surrey SM2 5NG, United Kingdom; The Breakthrough Breast Cancer Research Centre (S.Lin.), Institute of Cancer Research, London SW3 6JB, United Kingdom; and Dipartimento di Medicina Sperimentale (P.C.), II Università di Napoli, 80138 Naples, Italy
Address all correspondence and requests for reprints to: Giuseppe Portella, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Facoltà di Medicina e Chirurgia di Napoli, Università Federico II, via S. Pansini 5, 80131 Napoli, Italy. E-mail: portella{at}unina.it
Alterations in chromosome number (aneuploidy) are common in human neoplasias. Loss of mitotic regulation is believed to induce aneuploidy in cancer cells and act as a driving force during the malignant progression. The serine/theronine protein kinases of aurora family genes play a critical role in the regulation of key cell cycle processes. Aurora B mediates chromosome segregation by ensuring orientation of sister chromatids and overexpression of Aurora B in diploid human cells NHDF (normal human diploid fibroblast) induces multinuclearity.
We analyzed Aurora B expression in human thyroid carcinomas. Cell lines originating from different histotypes showed an increase in Aurora B expression. Immunohistochemical analysis of archive samples showed a high expression of Aurora B in anaplastic thyroid carcinomas; conversely, Aurora B expression was not detectable in normal thyroid tissue. Real-time PCR analysis confirmed a strong expression of Aurora B in anaplastic thyroid carcinomas.
The block of Aurora B expression induced by RNA interference or by using an inhibitor of Aurora kinase activity significantly reduced the growth of thyroid anaplastic carcinoma cells.
This article has been cited by other articles:
![]() |
M. Adler, K. Muller, E. Rached, W. Dekant, and A. Mally Modulation of key regulators of mitosis linked to chromosomal instability is an early event in ochratoxin A carcinogenicity Carcinogenesis, April 1, 2009; 30(4): 711 - 719. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C Smallridge, L. A Marlow, and J. A Copland Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies Endocr. Relat. Cancer, March 1, 2009; 16(1): 17 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wang, P. T. Stukenberg, and D. L. Brautigan Phosphatase Inhibitor-2 Balances Protein Phosphatase 1 and Aurora B Kinase for Chromosome Segregation and Cytokinesis in Human Retinal Epithelial Cells Mol. Biol. Cell, November 1, 2008; 19(11): 4852 - 4862. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Arlot-Bonnemains, E. Baldini, B. Martin, J.-G. Delcros, M. Toller, F. Curcio, F. S Ambesi-Impiombato, M. D'Armiento, and S. Ulisse Effects of the Aurora kinase inhibitor VX-680 on anaplastic thyroid cancer-derived cell lines Endocr. Relat. Cancer, June 1, 2008; 15(2): 559 - 568. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Gautschi, J. Heighway, P. C. Mack, P. R. Purnell, P. N. Lara Jr., and D. R. Gandara Aurora Kinases as Anticancer Drug Targets Clin. Cancer Res., March 15, 2008; 14(6): 1639 - 1648. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Chan, C. Sun, M. Perumal, Q.-D. Nguyen, V. Bavetsias, E. McDonald, V. Martins, N. E. Wilsher, F. I. Raynaud, M. Valenti, et al. Mechanism of action of the Aurora kinase inhibitor CCT129202 and in vivo quantification of biological activity Mol. Cancer Ther., December 1, 2007; 6(12): 3147 - 3157. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Carpinelli, R. Ceruti, M. L. Giorgini, P. Cappella, L. Gianellini, V. Croci, A. Degrassi, G. Texido, M. Rocchetti, P. Vianello, et al. PHA-739358, a potent inhibitor of Aurora kinases with a selective target inhibition profile relevant to cancer Mol. Cancer Ther., December 1, 2007; 6(12): 3158 - 3168. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Wiseman, H. Masoudi, P. Niblock, D. Turbin, A. Rajput, J. Hay, S. Bugis, D. Filipenko, D. Huntsman, and B. Gilks Anaplastic Thyroid Carcinoma: Expression Profile of Targets for Therapy Offers New Insights for Disease Treatment Ann. Surg. Oncol., February 1, 2007; 14(2): 719 - 729. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F Zeng, K. Navaratne, R. A Prayson, and R. J Weil Aurora B expression correlates with aggressive behaviour in glioblastoma multiforme J. Clin. Pathol., February 1, 2007; 60(2): 218 - 221. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Vischioni, J. J. Oudejans, W. Vos, J. A. Rodriguez, and G. Giaccone Frequent overexpression of aurora B kinase, a novel drug target, in non-small cell lung carcinoma patients. Mol. Cancer Ther., November 1, 2006; 5(11): 2905 - 2913. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, G. D. Kao, B. A. Garcia, J. Shabanowitz, D. F. Hunt, J. Qin, C. Phelan, and M. A. Lazar A novel histone deacetylase pathway regulates mitosis by modulating Aurora B kinase activity Genes & Dev., September 15, 2006; 20(18): 2566 - 2579. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shi, M. Zou, K. Collison, E. Y. Baitei, Z. Al-Makhalafi, N. R. Farid, and F. A. Al-Mohanna Ribonucleic Acid Interference Targeting S100A4 (Mts1) Suppresses Tumor Growth and Metastasis of Anaplastic Thyroid Carcinoma in a Mouse Model J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2373 - 2379. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. E. Nikiforov Anaplastic Carcinoma of the Thyroid--Will Aurora B Light a Path for Treatment? J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1243 - 1245. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |